Navigation Links
SynergEyes Hybrid Contact Lenses Provide a Vision Solution for Post-LASIK Patients
Date:4/25/2008

SAN DIEGO, April 25 /PRNewswire/ -- SynergEyes, Inc., of Carlsbad, CA, recently launched a revolutionary hybrid contact lens designed for people who need further vision correction after undergoing refractive vision surgery. SynergEyes(R) PS (post-surgical) is also designed for patients who have experienced some type of corneal trauma or suffer from certain degenerative vision conditions.

Every year, millions of people undergo LASIK or other types of vision correction surgery to restore vision and eliminate the need for glasses or contact lenses. But according to the U.S. Food and Drug Administration (FDA), approximately 5 percent of LASIK patients are dissatisfied with their outcome and experience post-operative conditions like eye pain, blurred or double vision and difficulty driving at night.

Because LASIK permanently alters the shape of the eye, traditional contact lenses and glasses often cannot provide the additional vision correction needed. This is why SynergEyes has developed a revolutionary contact lens designed specifically to address the technical challenges of restoring vision to these patients offering them consistent, predictable vision, even at night.

Approved for marketing by the FDA, SynergEyes(R) PS hybrid contact lenses combine two materials -- a rigid gas permeable center with a soft lens outer skirt. The "hybrid" design bonds a "hard" and "soft" contact lens together resulting in a one-of-a-kind vision correction option that provides crisp, clear vision for surgically altered corneas in a comfortable, healthy contact lens.

"The SynergEyes(R) PS lens has proven to be a safe, effective and comfortable lens for the restoration of post-surgical vision loss," says Dr. Edward Boshnick of Miami, FL. "It has become my first choice lens for the treatment of patients who have lost quality vision and comfort due to refractive and corneal transplant surgery."

Until being fit with SynergEyes(R) PS, Gabriel Meneses, a patient of Dr. Boshnick, had been struggling daily with post-LASIK side effects like blurry vision, ghosting and migraines after having the surgery six years ago. His vision could not be adequately corrected with eyeglasses or other contact lenses. "Dr Boshnick gave me the opportunity to be one of the first to try the new SynergEyes(R) PS lens ... all I can say is what a difference! As for vision quality, this lens has definitely offered me the best I've experienced so far."

Incorporating patented HyperBond(TM) technology and HydrolEyes(TM) surface science, the SynergEyes contact lenses with FDA market clearance include SynergEyes(R) A for naturally occurring ametropia, targeting patients with astigmatism, current gas permeable lens wearers, and patients demanding optimized vision; the SynergEyes(R) KC for keratoconus, the SynergEyes(R) Multifocal lens for presbyopia and the SynergEyes(R) PS for post-surgery and post trauma refractive errors.

Contact:

Kellie Kaseburg

Vice President of Global Marketing

kkaseburg@synergeyes.com

877.SEE.2012

http://synergeyes.com

This release was issued through eReleases(TM). For more information, visit http://www.ereleases.com.


'/>"/>
SOURCE SynergEyes, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. UT Southwestern testing new hybrid hearing device combining advantages of hearing aids, implants
2. Novel organic metal hybrids that will revolutionize materials science and chemical engineering
3. The trouble with hybrids
4. Nations Premiere Patient Advocate Organization Commits to UCN inContact(R) for Entire Group
5. $2.4 million grant for study of corneal infections associated with contact lenses
6. Personal Contact Helps Maintain Weight Loss
7. Grey House Publishing Acquires Hudsons Washington News Media Contacts Directory
8. Eyes on Puerto Rico: Johnson & Johnson Markets New Contact Lenses Directly to Consumers
9. New Study Finds Frequent Hand Washing Puts Health Care Workers at Increased Risk for Irritant Contact Dermatitis
10. New study finds resistant organisms at core of soft contact lens corneal infections
11. Contact lenses with circuits, lights a possible platform for superhuman vision
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/26/2017)... Ireland (PRWEB) , ... February 26, 2017 , ... ... as in 2011 the lab became the world’s first to be ISO/IEC 17025:2005 ... 1 (cat allergen) analysis. , ISO/IEC 17025:2005 is the globally recognised standard that ...
(Date:2/26/2017)... KS (PRWEB) , ... February ... ... StaffBridge sets a new technology standard in staffing, scheduling, and reporting for ... monitor, and predict activity throughout the entire staffing process. StaffBridge technology improves ...
(Date:2/25/2017)... Aliso Viejo, CA (PRWEB) , ... February 25, 2017 , ... ... luminance with ProSharpen Color tools from Pixel Film Studios. With ProSharpen Color users have ... alpha sliders to easily refine their color range. With color spectrum tools users can ...
(Date:2/24/2017)... ... February 24, 2017 , ... WHAT: , The New Jersey ... as well as advocacy for the state and region‘s technology businesses, hosted their ... The Council's Innovation Forecast event highlights innovation throughout the region from small to ...
(Date:2/24/2017)... New York, NY (PRWEB) , ... February 24, 2017 , ... ... urges: “Security needs to be a top priority because it’s not if you will ... in online safety, especially when it comes to digital health care. , Improvements in ...
Breaking Medicine News(10 mins):
(Date:2/24/2017)... , Australien, 24. Februar 2017 ITL ... Unternehmen des Gesundheitsbereiches, ist erfreut, für das zum ... dem entsprechenden Vorjahreszeitraum exzellente Ergebnisse vorlegen zu können. ... Aktualisierung zum Wachstum" finden Sie hier . ... Gewinn nach Steuern 2,12 Millionen USD (Dez. 2015: 1,04 Millionen USD; +104 %) ...
(Date:2/24/2017)... 2017  Directors from Pharma To Market Pty Ltd and Ador ... resulting in the founding of Pharma To Market Pte Ltd, based ... are pleased to announce their expansion into Asia ... . The company are delighted to appoint Joelle Chia ... Singapore based entity. Joelle brings with her an ...
(Date:2/24/2017)... 2017 Non-alcoholic steatohepataitis (NASH) Pipeline ... drugs being developed for the treatment of ... that are in various phases of development ... on novel pharmacologic drugs & regenerative medicines ... recombinant proteins and RNA-based therapeutics, but excludes ...
Breaking Medicine Technology: